Pronounced differences in the estimation of breast cancer mortality in connection with hormone replacement therapy and mammographic screening
Jørgensen, K.Juhl.
Ugeskrift for Laeger 166(15-16): 1465
2004
ISSN/ISBN: 0041-5782 PMID: 15146820 Document Number: 570414
Document emailed within 1 workday
Related Documents
Schouten, L.J.; de Rijke, J.M.; Schlangen, J.T.; Verbeek, A.L. 1997: Hormone replacement therapy and high incidence of breast cancer between mammographic screens Lancet 349(9058): 1104Andersson, I.; Aspegren, K.; Janzon, L.; Landberg, T.; Lindholm, K.; Linell, F.; Ljungberg, O.; Ranstam, J.; Sigfússon, B. 1988: Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial Bmj 297(6654): 943-948
Tabár, L.; Fagerberg, G.; Day, N.E.; Duffy, S.W. 1992: The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics Pathologie-Biologie 39(9): 846
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Snyder, G.M.; Sielsch, E.C.; Reville, B. 1998: The controversy of hormone-replacement therapy in breast cancer survivors Oncology Nursing Forum 25(4): 699-706; Quiz: 707-708
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Cobleigh, M.A.; Norlock, F.E.; Oleske, D.M.; Starr, A. 1999: Hormone replacement therapy and high S phase in breast cancer JAMA 281(16): 1528-1530
Meurer, L.N.; Lená, S. 2002: Cancer recurrence and mortality in women using hormone replacement therapy: meta-analysis Journal of Family Practice 51(12): 1056-1062
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Ersbøll, J. 2004: Breast cancer, mammography screening and hormone therapy Ugeskrift for Laeger 166(36): 3113-3114
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Ratanawichitrasin, A.; Reansuwan, W.; Ratanawichitrasin, S.; Bhodhisuwan, K.; Kongpatanakul, S. 2002: Risk of breast cancer in post-menopausal women using hormone replacement therapy Journal of the Medical Association of Thailand 85(5): 583-589
This, P. 1996: Hormone replacement therapy in menopausal women previously treated for breast cancer Presse Medicale 25(4): 141-144
Landsveld-Verhoeven, C.; den Heeten, G.J.; Timmers, J.M.H.; Broeders, M.J.M. 2015: The correct mammographic positioning in breast cancer screening Nederlands Tijdschrift Voor Geneeskunde 159: A9488
Erichsen, G.G. 1994: Mammographic screening for breast cancer--only to my worst enemy? Ugeskrift for Laeger 156(24): 3643-3645
Moskowitz, M.; Libshitz, H.I. 1977: Mammographic screening for breast cancer by lateral view only: is it practical? Journal of the Canadian Association of Radiologists 28(4): 259-261
Lányi, M.; László, G.; Farkas, M. 1970: Combined clinical and mammographic mass screening in breast cancer Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 11(1): 18-26
Barda, L.; Nevler, A.; Rosin, D.; Shabtai, E.L.; Gutman, M.; Shabtai, M. 2019: The effects of Hormonal Replacement Therapy (Hrt) on Mammographic Breast Density and Abnormal Mammograms Prompting Further Investigation Harefuah 158(4): 239-243
Den Otter, W.; Merchant, T.E.; Beijerinck, D.; Koten, J.W. 1996: Breast cancer induction due to mammographic screening in hereditarily affected women Anticancer Research 16(5b): 3173-3175